These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17724446)

  • 1. Long-term outcomes in children with high-risk neuroblastoma treated with autologous stem cell transplantation.
    Trahair TN; Vowels MR; Johnston K; Cohn RJ; Russell SJ; Neville KA; Carroll S; Marshall GM
    Bone Marrow Transplant; 2007 Oct; 40(8):741-6. PubMed ID: 17724446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update.
    George RE; Li S; Medeiros-Nancarrow C; Neuberg D; Marcus K; Shamberger RC; Pulsipher M; Grupp SA; Diller L
    J Clin Oncol; 2006 Jun; 24(18):2891-6. PubMed ID: 16782928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term adverse effects on dentition in children with poor-risk neuroblastoma treated with high-dose chemotherapy and autologous stem cell transplantation with or without total body irradiation.
    Hölttä P; Alaluusua S; Saarinen-Pihkala UM; Wolf J; Nyström M; Hovi L
    Bone Marrow Transplant; 2002 Jan; 29(2):121-7. PubMed ID: 11850706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term effect of high dose chemotherapy combined with stem cell transplantation on stage IV neuroblastoma in children].
    Tang SQ; Huang DS; Wang JW; Feng C; Yang G
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr; 8(2):93-6. PubMed ID: 16613697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes in patients with stage IV neuroblastoma.
    Escobar MA; Grosfeld JL; Powell RL; West KW; Scherer LR; Fallon RJ; Rescorla FJ
    J Pediatr Surg; 2006 Feb; 41(2):377-81. PubMed ID: 16481255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term complications in survivors of advanced stage neuroblastoma.
    Laverdière C; Cheung NK; Kushner BH; Kramer K; Modak S; LaQuaglia MP; Wolden S; Ness KK; Gurney JG; Sklar CA
    Pediatr Blood Cancer; 2005 Sep; 45(3):324-32. PubMed ID: 15714447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Veno-occlusive disease of the liver in children with solid tumors undergoing autologous hematopoietic progenitor cell transplantation: a high incidence in patients with neuroblastoma.
    Horn B; Reiss U; Matthay K; McMillan A; Cowan M
    Bone Marrow Transplant; 2002 Mar; 29(5):409-15. PubMed ID: 11919731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival after relapse in children with solid tumors: a follow-up study from the Italian off-therapy registry.
    Ceschel S; Casotto V; Valsecchi MG; Tamaro P; Jankovic M; Hanau G; Fossati F; Pillon M; Rondelli R; Sandri A; Silvestri D; Haupt R; Cuttini M
    Pediatr Blood Cancer; 2006 Oct; 47(5):560-6. PubMed ID: 16395684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of autologous stem cell transplantation in light chain deposition disease.
    Lorenz EC; Gertz MA; Fervenza FC; Dispenzieri A; Lacy MQ; Hayman SR; Gastineau DA; Leung N
    Nephrol Dial Transplant; 2008 Jun; 23(6):2052-7. PubMed ID: 18178602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tandem stem cell rescue as consolidation therapy for high-risk neuroblastoma.
    Qayed M; Chiang KY; Ricketts R; Alazraki A; Tahvildari A; Haight A; George B; Esiashvili N; Katzenstein HM
    Pediatr Blood Cancer; 2012 Mar; 58(3):448-52. PubMed ID: 21538822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma.
    Toporski J; Garkavij M; Tennvall J; Ora I; Gleisner KS; Dykes JH; Lenhoff S; Juliusson G; Scheding S; Turkiewicz D; Békássy AN
    Biol Blood Marrow Transplant; 2009 Sep; 15(9):1077-85. PubMed ID: 19660720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High rate of long-term survival for high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy.
    Espigado I; Ríos E; Marín-Niebla A; Carmona M; Parody R; Pérez-Hurtado JM; Márquez FJ; Urbano-Ispizua A
    Transplant Proc; 2008 Nov; 40(9):3104-5. PubMed ID: 19010208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of high-risk relapsed Wilms tumor with dose-intensive chemotherapy, marrow-ablative chemotherapy, and autologous hematopoietic stem cell support: experience by the Italian Association of Pediatric Hematology and Oncology.
    Spreafico F; Bisogno G; Collini P; Jenkner A; Gandola L; D'Angelo P; Casazza G; Piva L; Luksch R; Perotti D; Pession A; Fagioli F; Dallorso S
    Pediatr Blood Cancer; 2008 Jul; 51(1):23-8. PubMed ID: 18293386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical features and prognosis of advanced neuroblastoma in children].
    Gao XN; Tang SQ; Lin J
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):351-4. PubMed ID: 17706038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma.
    Wildes TM; Augustin KM; Sempek D; Zhang QJ; Vij R; Dipersio JF; Devine SM
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):840-6. PubMed ID: 18541205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome.
    Butturini AM; Jacob M; Aguajo J; Vander-Walde NA; Villablanca J; Jubran R; Erdreich-Epstein A; Marachelian A; Dhall G; Finlay JL
    Cancer; 2009 Jul; 115(13):2956-63. PubMed ID: 19402050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
    Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
    Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of TBI on late effects in children treated by megatherapy for Stage IV neuroblastoma. A study of the French Society of Pediatric oncology.
    Flandin I; Hartmann O; Michon J; Pinkerton R; Coze C; Stephan JL; Fourquet B; Valteau-Couanet D; Bergeron C; Philip T; Carrie C
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1424-31. PubMed ID: 16427213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous stem cell transplantation for Hodgkin's lymphoma: results and prognostic factors in 51 high-risk patients.
    Sperotto A; Damiani D; Zaja F; Patriarca F; Geromin A; Cerno M; Stocchi R; Tiribelli M; Skert C; Rinaldi C; Fanin R
    Adv Clin Path; 2002 Apr; 6(2):77-85. PubMed ID: 19753729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.